RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,200,000 | -35.4% | 25,000 | -36.9% | 0.01% | +66.7% |
| Q4 2019 | $1,858,000 | -25.5% | 39,589 | -62.5% | 0.01% | -25.0% |
| Q3 2019 | $2,495,000 | +103.5% | 105,517 | +158.8% | 0.01% | +100.0% |
| Q2 2019 | $1,226,000 | -73.8% | 40,764 | -80.5% | 0.00% | -73.3% |
| Q1 2019 | $4,683,000 | +2863.9% | 209,060 | +1214.8% | 0.02% | – |
| Q2 2018 | $158,000 | -63.6% | 15,900 | -80.5% | 0.00% | -100.0% |
| Q1 2018 | $434,000 | +164.6% | 81,689 | +322.1% | 0.00% | 0.0% |
| Q4 2017 | $164,000 | – | 19,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
| NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
| Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
| Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
| Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
| VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
| Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
| Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
| Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |